These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 9365617

  • 1. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
    Behrend M, Lueck R, Pichlmayr R.
    Transplant Proc; 1997 Nov; 29(7):2927-9. PubMed ID: 9365617
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A, Sasvári I, Toronyi E, Borka P, Lázár N, Járay J, Perner F.
    Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K, Moon JI, Kim SI, Kim YS.
    Transplant Proc; 1999 May; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
    Transplant Proc; 1997 May; 29(1-2):348-9. PubMed ID: 9123033
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective study of mycophenolate mofetil for the prevention of acute rejection in living donor renal allograft recipients.
    Park K, Kim SI, Moon JI, Kim YS, Kim MS.
    Transplant Proc; 1998 Nov; 30(7):3575. PubMed ID: 9838565
    [No Abstract] [Full Text] [Related]

  • 10. A single center experience with mycophenolate mofetil in the prevention of renal allograft rejection.
    Behrend M, Lück R, Köthe P, Pichlmayr R.
    Transplant Proc; 1996 Dec; 28(6):3110-1. PubMed ID: 8962205
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
    Sells RA, Bakran A, Brown MW, Grinyo J, Hammad A, Hyatt D, Owens G.
    Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Dominguez-Gil B, Carreño A, Delgado M, Manzanares C.
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract] [Full Text] [Related]

  • 14. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP, Weinreich T, Schwarzkopf AK, Candinas D, Binswanger U.
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract] [Full Text] [Related]

  • 15. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A, Herrero JC, Morales E, Carreño A, Dominguez-Gil B, Cirujeda A, Praga M, Ortuño T, Hernandez E, Delgado M, Andres A, Morales JM.
    Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
    Altaca G, Berber I, Aydin C, Yigit B, Aydin M, Titiz I.
    Transplant Proc; 2001 Sep; 33(7-8):3248-9. PubMed ID: 11750391
    [No Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B, Rochat P, Schwarzkopf AK, Weinreich T, Binswanger U.
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract] [Full Text] [Related]

  • 18. Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J.
    Transplant Proc; 1999 Dec; 31(1-2):276-7. PubMed ID: 10083106
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC, Park SB, Kim HT, Cho WH, Park CH.
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N, Goggins M, Nori U, Abouljoud M, Zasuwa G, Venkat KK, Parasuraman R.
    Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.